About 200 reports

Psoriatic arthritis

4546 5000 3864
  • FRANCE PSORIATIC ARTHRITIS TREATMENT RATE AND USAGE OF BIOLOGIC THERAPIES, BY DISEASE SEVERITY AND LINE OF THERAPY
  • GERMANY PSORIATIC ARTHRITIS TREATMENT RATE AND USAGE OF BIOLOGIC THERAPIES, BY DISEASE SEVERITY AND LINE OF THERAPY
  • Biological Therapy
  • Amgen Inc.
  • Celgene Corporation
  • Johnson & Johnson
  • Novartis AG

##. ##. ## ALS: Could this Rare Disease be the First Neurodegenerative Condition for Stem Cell Treatment?

  • Biological Therapy
  • Stem Cell
  • World

Physician Views: Can new biologic therapies expand the severe asthma market?

  • Asthma
  • Biological Therapy
  • Therapy
  • United States
  • Forecast
  • Date

In U. S., FDA CBER and CDRH regulate cell therapy, gene therapy, tissue engineered products and is empowered to regulate biologic products and hence stem cells in the U. S.

  • Biological Therapy
  • World
  • Market Size
  • Eppendorf AG
  • GE Healthcare Limited

The innovative biologic therapies and their biosimilar counterparts hold promise for patients suffering from chronic diseases.

  • Biological Therapy
  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Pharmaceutical

(Samsung Biologics).

  • Biological Therapy
  • Biopharmaceutical
  • Monoclonal Antibody
  • World
  • Market Size

Chemotherapy may be used alone or with RT or a biological therapy.

  • Biological Therapy
  • Cancer
  • Leukemia
  • Monoclonal Antibody
  • Pathology
  • EFFICACY OF OTHER BIOLOGIC THERAPIES (CAMPATH/LEMTRADA AND RITUXAN) IN GVHD
  • PROVIDES A SWOT ANALYSIS OF OTHER BIOLOGIC THERAPIES (CAMPATH/LEMTRADA AND RITUXAN).
  • Biological Therapy
  • Athersys, Inc.
  • Fresenius Group
  • GlobalData's company
  • Soligenix, Inc.

Biologics: Targets and Therapy; ##(##): ##-##.

  • Biological Therapy
  • Cancer
  • Cancer Immunotherapy
  • Therapy
  • Vaccine
  • MERCK
  • LONZA

LONZA: OPPORTUNITY ASSESSMENT Opportunity Assessment Merck delivers novel health solutions through its prescription medicines, biologic therapies, and consumer care products.

  • Biological Therapy
  • World
  • Forecast
  • Merck & Co., Inc.
  • Sanofi S.A.
  • 2.1 TYPES OF STEM CELLS

Intellectual property challenges The granting of intellectual property rights (IPRs) for biological forms has been controversial.

  • Biological Therapy
  • Cynata Therapeutics Limited
  • Mesoblast Limited
  • NuVasive, Inc.
  • Orthofix International N.V.
  • IV
  • Immunotherapy Drugs Sales Volume

Shenzhen Kangtai Biological Products Co., Ltd. is the biggest cancer vaccines producer in China.

  • Biological Therapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • MARKET OVERVIEW

The drug is the only approved first-line biologic in the region for the treatment of psoriasis.

  • Biological Therapy
  • Biogen Idec Inc.
  • Novo Nordisk Group
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

Secondary objectives are to evaluate clinical efficacy and biologic activity.

  • Biological Therapy
  • United States
  • Advantagene, Inc.
  • Celsion Corporation
  • Takara Bio Inc.

The three main technologies used in regenerative medicine are small molecules and biologics, gene therapy, and cell therapy.

  • Biological Therapy
  • Biotechnology
  • Molecular Biology
  • Tissue Engineering
  • Japan

Mepolizumab is the first-in-class anti-IL-## biologic therapy.

  • Biological Therapy
  • Clinical Trial
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc

Gene therapies segment is expected to be the fastest emerging technology due to tremendous potential of gene therapy in minimizing immune rejections, which commonly occur after transplantations.

  • Biological Therapy
  • Molecular Biology
  • Tissue Engineering
  • World
  • Forecast

THIS ALLIANCE WAS FORMED ON A PRIOR AGREEMENT BETWEEN WUXI BIOLOGICS AND MEDIMMUNE ON THE DEVELOPMENT AND COMMERCIALIZATION OF MEDI##, A NOVEL BIOLOGIC DEVELOPED FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES.

  • Biological Therapy
  • World
  • Biologics, Inc.
  • Catalent Pharma Solutions, Inc.
  • Lonza Group Ltd
  • 9. KEY THERAPEUTIC AREAS FOR T-CELL THERAPIES
  • 6. T-CELL RECEPTOR (TCR) BASED THERAPIES

CMC BIOLOGICS ##. ##. ##.

  • Biological Therapy
  • United States
  • Juno Therapeutics Inc.
  • Kite Pharma, Inc.
  • Novartis AG

OTHER BIOLOGICS INCLUDE GENE THERAPIES, FUSION PROTEINS, UNSPECIFIED BIOLOGICAL MOLECULES INCLUDING IMETELSTAT (PHASE III), ABT-## (PHASE I) AND AMC## (PHASE I).

  • Biological Therapy
  • United States
  • Demand
  • AstraZeneca PLC
  • Novartis AG

THE TREATMENT THROUGH BIOLOGICS IS GENERALLY VERY EXPENSIVE.

  • Biological Therapy
  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Pharmaceutical
  • 5. VIRAL VECTORS

COBRA BIOLOGICS ##. ##. ##.

  • Biological Therapy
  • United States
  • Market Size
  • MolMed S.p.A.
  • uniQure N.V.
  • IMCGP100: CURRENT STATUS OF DEVELOPMENT
  • highlights the forecasted growth of the overall CAR-T cells market spanning

NOVEL TREATMENTS FORM ANOTHER ARM OF THE AVAILABLE THERAPIES WHICH INCLUDES THE BIOLOGIC THERAPY.

  • Biological Therapy
  • United States
  • Cellectis S.A.
  • Juno Therapeutics Inc.
  • Kite Pharma, Inc.

The company mainly focuses on various health solutions such as prescription medicines, vaccines, biologic therapies, animal health and biologic products worldwide.

  • Biological Therapy
  • Bioheart, Inc.
  • Celladon Corporation
  • GlaxoSmithKline plc
  • Juventas Therapeutics, Inc.
  • BIOLOGICAL THERAPY WITH OR WITHOUT SURGERY IN TREATING PATIENTS WITH KIDNEY CANCER
  • Clinical Trial profile. 81 Trial Title
  • Biological Therapy
  • Clinical Trial
  • Hospital
  • Renal Cancer
  • Pfizer Inc.

BIOMET BIOLOGICS/ BIOMET CLINICALTRIALS.

  • Biological Therapy
  • United States
  • Athersys, Inc.
  • ISCC
  • Vericel Corporation

This therapy will be reviewed under the PMA regulations by the FDA' s Center for Biologics Evaluation and Research (CBER) division.

  • Biological Therapy
  • Cardiology
  • Heart Failure
  • United States
  • BioCardia, Inc.
  • Deal Type

" Recent publications and presentations continue to illustrate how we might be able to extend the treatment window for stroke patients out to ## hours with MultiStem, beyond the narrow window for treatment that exists today, and also the important biological mechanisms

  • Biological Therapy
  • Stroke
  • United States
  • Company
  • Athersys, Inc.
  • May 10, 2017: Article by Professor Johnny Ludvigsson on clinical trials with Diamyd published in Expert Opinion on Biological Therapy
  • PF-05285401 - DRUG PROFILE
  • Biological Therapy
  • Chronic Disease
  • Insulin
  • Pathology
  • Type 1 Diabetes
  • Year
  • BRISTOL-MYERS SQUIBB (U.S.)

ENDOTOXIN TESTING IS USED IN CELL THERAPY, MONOCLONAL ANTIBODY TESTING, VACCINE TESTING, GENE THERAPY, AND DRUG DEVELOPMENT.

  • Biological Therapy
  • World
  • Company
  • Product Initiative
  • Merck & Co., Inc.